Loss of tooth mineral, demineralization, is the root cause of dental ailments - the most prevalent health problems affecting over 90 percent of Americans. These range from white spot lesions, the earliest sign of dental demineralization, to periodontal diseases, which can lead to more serious health issues. Current restorative treatments of tooth structure and function utilize synthetic materials, e.g. amalgam, glass ionomers, and particle reinforced resin composites that lead to deposited secondary precipitates. Although these common procedures are well-established and relatively effective, their durability is limited due to lack of structural and functional integration of deposited layer with the underlying tooth. GEMSEC labs have developed a proprietary technology dubbed “peptide-guided remineralization” which enables the formation of a new mineral with protein-derived peptides. Using this technology, the lab teams have successfully restored dental hard tissues via several case studies including enamel, cementum, dentin under in vitro and in vivo conditions. Translating this technology into a daily-use product, we developed a prototype, dental lozenges, designed to aid in enamel remineralization using a biomineralizing peptide, ADP5, derived from amelogenin, the key enamel protein. Herein we aim to refine the lozenge formulation through an iterative study for enhanced durable and whitening remineralized layer. Remineralization performance of different tablet formulations were tested in artificial saliva using extracted human enamel teeth. The samples were characterized using SEM showing that the current lozenge formulation creates a new mineral layer on enamel up to 2 µm in thickness. In summary, the new lozenge artificially regenerates lost enamel on the molecular level to treat tooth decay and erosion. Developed through a simple biomimetic methodology, this prototype lozenge could be mass fabricated for the consumer dental care market and expanded to include dental varnishes, gels, and pastes.